COVID-19 Clinical Trial
Official title:
Burnout, Emotional Distress and Needs in Frontline COVID-19 Healthcare Workers: Cross-sectional Study in a Belgian Population
Background: In the Covid-19 pandemic context, all healthcare teams face clinical,
organizational and technical challenges given the contagion, severity and mortality
characteristics of the disease. A study reported the negative psychological impact on
healthcare workers of this new situation, in terms of depression, anxiety and distress.
Working in frontline constitutes an independent risk factor for worse mental health outcomes.
Methods: This is a cross-sectional study aiming to compare levels of burnout, emotional
distress and needs between frontline Covid-19 and non-Covid-19 healthcare workers. Any
physician, nurse and physiotherapist will be recruited from emergency care units and Covid-19
care units (target group) and from non-Covid-19 care units (control group) from different
hospitals in Belgium. The participation will occur on a voluntary basis. Participants will be
recruited from April 15th 2020 to May 15th 2020. Participants will complete self-reported
questionnaires and scales. A mixed-mode data collection will be carried out, either in paper
or web-based form. This mixed-mode survey will ensure the highest range of participants,
considering the hygiene and organizational requirements for target care units. Assessment
will provide socio-demographic characteristics and professional information. It will also
measure professional fulfillment and burnout with the Stanford Professional Fulfillment Index
(PFI), emotional distress with the Depression, Anxiety and Distress Scale-Short Form
(DASS-21), sleep disturbance with the Insomnia Severity Index (ISI) and needs with the Needs
and Difficulties Inventory (developed for the study).
Hypothesis: This study is based on the hypothesis that higher levels of burnout, depression,
anxiety and stress will be found in frontline Covid-19 healthcare workers than in
non-Covid-19 healthcare workers. Considering the unprecedented challenges for healthcare
workers and organizations, and considering the exploratory nature of the study, no hypothesis
is made for the needs of the healthcare workers.
Statistical Analysis: Means and standard deviation will be calculated for the PFI, the
DASS-21, the ISI and the NDI. Multivariate Analysis of Variance (MANOVA) will be performed
including the PFI, the DASS-21 and the ISI scores to test the effect of group (work
position), occupation and the two-way group × occupation interaction effect. Age, gender,
profession, sector of activity, job status and job experience will be entered as covariate.
Odds ratio will be also provided. All tests are two-tailed and alpha is set at .05. All
analyzes will be performed using IBM SPSS®, version 26.
This is a cross-sectional comparative study based on self-reported questionnaires and scales
(validated for the most part) assessing the levels of burnout, emotional distress, sleep
disturbance and needs in frontline Covid-19 healthcare workers vs non-Covid-19 healthcare
workers. The enrollment and the course of the study will be carried out on site. Participants
are volunteers and are informed about the objectives and methods of the study.
Any physician, nurse or physiotherapist (referred as "healthcare worker") actively working in
a medical care unit from different medical facilities will be informed of the study. An email
containing information regarding the study and its implications will be sent. If required by
the care unit they work in, potential participants will also be invited to a one-time
information session. Potential participants will also be given an information form during
this oral information session. Participants will be recruited from April 15th to May 15th
2020.
The assessment will be proposed by paper or web-based self-reported questionnaires and
scales. This mixed-mode survey will not be randomized and will ensure the highest range of
participants, considering the hygiene and organizational requirements in the target units.
The assessment time will be proposed at the participant's inclusion. Because of the
mixed-mode survey and anonymity of data, the completion of questionnaires and scales will be
considered as informed consent as stated in the information form received by the
participants.
The questionnaires and scales include sociodemographic characteristics, professional
information, the Professional Fulfillment Index (PFI), the Depression, Anxiety and Stress
Scale-Short Form (DASS-21), the Insomnia Severity Index (ISI) and the Needs and Difficulties
Inventory (NDI, developed for the study).
Healthcare workers from emergency units, non-intensive Covid-19 and intensive Covid-19 units
will be in the target group. Healthcare workers from non-Covid-19 units will be in the
control group. In terms of enrollment, 200 participants (100 in each group) are expected. The
objectives of the study will be reached by statistical comparison of these groups.
In terms of data collection, the data manager collects data from paper version and electronic
version. For the paper version, participants will be able to deposit their assessment in
specific drop boxes available in the concerned care units. Then, data manager's assistant
will be in charge of producing a digital copy. The data from the paper version will undergo
double encoding (by two assistants, not linked to the principal investigator) in order to
reduce encoding errors. The electronic data will be stored on a secure platform, linked to
the Free University of Brussels. The paper version will be stored in a secure location within
Erasme Hospital (Brussels, Belgium), accessible only by the principal investigator and the
data manager. Evaluations, whether paper or electronic, will be destroyed 1 month after study
completion date.
Statistical analysis will consist firstly in a comparative analysis of participants'
sociodemographic and professional characteristics using Chi-squared (or Student t test,
Mann-Whitney U test when applicable for continuous variable) test for each categorical
variable. Secondly, descriptive analyses will be performed on severity categories for
professional fulfillment, burnout, insomnia, depression, anxiety and stress. Differences
between groups regarding severity levels will be tested using X2. A two-way MANOVA will be
used to test main effects of working position (group effect), occupation type (occupation
effect) and to test a group × occupation interaction effect on fulfillment, burnout, insomnia
and mental health scores. The two-way MANOVA will be adjusted for age, gender, marital
status, workload and job status. Multivariable logistic regression analyses will be performed
to estimate risk factors for burnout, clinically significant insomnia and severe to extremely
severe depression, anxiety and stress. These will be presented as odds ratios, with 95%
confidence intervals, adjusting for confounders. All tests will be two-tailed and alpha was
set at .05. All analyses will be performed using IBM SPSS® v26.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT06065033 -
Exercise Interventions in Post-acute Sequelae of Covid-19
|
N/A | |
| Completed |
NCT06267534 -
Mindfulness-based Mobile Applications Program
|
N/A | |
| Completed |
NCT05047601 -
A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05323760 -
Functional Capacity in Patients Post Mild COVID-19
|
N/A | |
| Recruiting |
NCT04481633 -
Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection
|
N/A | |
| Completed |
NCT04537949 -
A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults
|
Phase 1/Phase 2 | |
| Completed |
NCT04612972 -
Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru
|
Phase 3 | |
| Recruiting |
NCT05494424 -
Cognitive Rehabilitation in Post-COVID-19 Condition
|
N/A | |
| Active, not recruiting |
NCT06039449 -
A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2
|
Phase 3 | |
| Enrolling by invitation |
NCT05589376 -
You and Me Healthy
|
||
| Completed |
NCT05158816 -
Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
|
||
| Recruiting |
NCT04341506 -
Non-contact ECG Sensor System for COVID19
|
||
| Completed |
NCT04512079 -
FREEDOM COVID-19 Anticoagulation Strategy
|
Phase 4 | |
| Completed |
NCT04384445 -
Zofin (Organicell Flow) for Patients With COVID-19
|
Phase 1/Phase 2 | |
| Completed |
NCT05975060 -
A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants.
|
Phase 2/Phase 3 | |
| Active, not recruiting |
NCT05542862 -
Booster Study of SpikoGen COVID-19 Vaccine
|
Phase 3 | |
| Withdrawn |
NCT05621967 -
Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation
|
N/A | |
| Terminated |
NCT05487040 -
A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease
|
Phase 1 | |
| Terminated |
NCT04498273 -
COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80
|
Phase 3 | |
| Active, not recruiting |
NCT06033560 -
The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure
|